FDAnews Drug Daily Bulletin

PERLEGEN SCIENCES FILES FOR IPO

April 12, 2006
A A

Biopharmaceutical company Perlegen Sciences Inc. registered Monday for an initial public offering of up to $115 million in common stock, according to a filing with the Securities and Exchange Commission. Newsfactor Magazine Online (http://www.newsfactor.com/news/Perlegen-Sciences-Files-for-IPO/story.xhtml?story_id=022001ZOWSKA)